BACKGROUND:Psychological distress tolerance, the ability to persist in goal directed activity when experiencing psychological distress, is associated with poor substance use treatment outcomes including drug and alcohol treatment dropout and relapse. OBJECTIVE: The current study examines if a brief distress tolerance intervention that was specifically developed as an adjunctive treatment for patients in residential substance abuse treatment shows efficacy in improving the patients' distress tolerance. METHODS:Seventy-six individuals who were receiving treatment at a residential substance use treatment facility and indexed low distress tolerance on laboratory distress tolerance measures were randomized into three conditions: treatment-as-usual (TAU), six sessions of Supportive Counseling (SC), or six sessions of the novel distress tolerance treatment, Skills for Improving Distress Intolerance (SIDI). MEASURES: Patients were assessed at baseline for DSM-IV psychiatric diagnoses, DSM-IV substance use disorders, distress tolerance, and depressive symptoms. Patients were again assessed at posttreatment. Therapeutic alliance and treatment expectancies and credibility were also assessed at posttreatment. RESULTS: Patients who received SIDI (n=28) evidenced significantly greater improvements than SC (n=24) and TAU participants (n=24) on the distress tolerance laboratory measures, even when controlling for changes in negative affect (in the form of depression). Additionally, a higher percentage of patients in SIDI reached clinically significant improvement compared to patients in SC and TAU. CONCLUSION: This study supports the efficacy of SIDI in improving distress tolerance levels among individuals with drug and alcohol use disorders currently receiving residential substance use treatment. SIDI appears to be a brief and feasible intervention for use within inpatient substance use facilities.
RCT Entities:
BACKGROUND: Psychological distress tolerance, the ability to persist in goal directed activity when experiencing psychological distress, is associated with poor substance use treatment outcomes including drug and alcohol treatment dropout and relapse. OBJECTIVE: The current study examines if a brief distress tolerance intervention that was specifically developed as an adjunctive treatment for patients in residential substance abuse treatment shows efficacy in improving the patients' distress tolerance. METHODS: Seventy-six individuals who were receiving treatment at a residential substance use treatment facility and indexed low distress tolerance on laboratory distress tolerance measures were randomized into three conditions: treatment-as-usual (TAU), six sessions of Supportive Counseling (SC), or six sessions of the novel distress tolerance treatment, Skills for Improving Distress Intolerance (SIDI). MEASURES: Patients were assessed at baseline for DSM-IV psychiatric diagnoses, DSM-IV substance use disorders, distress tolerance, and depressive symptoms. Patients were again assessed at posttreatment. Therapeutic alliance and treatment expectancies and credibility were also assessed at posttreatment. RESULTS:Patients who received SIDI (n=28) evidenced significantly greater improvements than SC (n=24) and TAU participants (n=24) on the distress tolerance laboratory measures, even when controlling for changes in negative affect (in the form of depression). Additionally, a higher percentage of patients in SIDI reached clinically significant improvement compared to patients in SC and TAU. CONCLUSION: This study supports the efficacy of SIDI in improving distress tolerance levels among individuals with drug and alcohol use disorders currently receiving residential substance use treatment. SIDI appears to be a brief and feasible intervention for use within inpatient substance use facilities.
Authors: Thomas H Brandon; Thaddeus A Herzog; Laura M Juliano; Jennifer E Irvin; Amy B Lazev; Vani Nath Simmons Journal: J Abnorm Psychol Date: 2003-08
Authors: Stacey B Daughters; Elizabeth K Reynolds; Laura MacPherson; Christopher W Kahler; Carla K Danielson; Michael Zvolensky; C W Lejuez Journal: Behav Res Ther Date: 2008-12-13
Authors: Daniel N Klein; Joseph E Schwartz; Neil J Santiago; Dina Vivian; Carina Vocisano; Louis G Castonguay; Bruce Arnow; Janice A Blalock; Rachel Manber; John C Markowitz; Lawrence P Riso; Barbara Rothbaum; James P McCullough; Michael E Thase; Frances E Borian; Ivan W Miller; Martin B Keller Journal: J Consult Clin Psychol Date: 2003-12
Authors: Michael W Otto; Bridget A Hearon; R Kathryn McHugh; Amanda W Calkins; Elizabeth Pratt; Heather W Murray; Steven A Safren; Mark H Pollack Journal: J Psychoactive Drugs Date: 2014 Nov-Dec
Authors: Ian H Stanley; Joseph W Boffa; Lia J Smith; Jana K Tran; N Brad Schmidt; Thomas E Joiner; Anka A Vujanovic Journal: Psychiatry Res Date: 2018-05-24 Impact factor: 3.222
Authors: RaeAnn E Anderson; Erin E Bonar; Maureen A Walton; Jason E Goldstick; Sheila A M Rauch; Quyen M Epstein-Ngo; Stephen T Chermack Journal: J Stud Alcohol Drugs Date: 2017-07 Impact factor: 2.582
Authors: Richard J Macatee; Nicholas P Allan; Agnieszka Gajewska; Aaron M Norr; Amanda Medley Raines; Brian J Albanese; Joseph W Boffa; Norman B Schmidt; Jesse R Cougle Journal: Cognit Ther Res Date: 2015-08-15
Authors: Samantha G Farris; Teresa M Leyro; Nicholas P Allan; Camilla S Øverup; Norman B Schmidt; Michael J Zvolensky Journal: Behav Res Ther Date: 2016-08-03